Objective: To contribute to clarify molecular mechanisms supporting senescence and de-differentiation of chondrocytes in chondrocyte pathologies such as osteoarthritis (OA). Specifically, we investigated the relationship between the nuclear lamina protein Lamin B1 and the negative regulator of chondrogenesis Slug transcription factor in osteoarthritic chondrocytes. Methods: Lamin B1 and Slug proteins were analyzed in cartilage explants from normal subjects and OA patients by immunohistochemical technique. Their expression was confirmed on isolated chondrocytes both at passage 0 and passage 2 (de-differentiated chondrocytes) by immunofluorescence and western blot. Subsequently, we explored the "in vivo" binding of Slug on LMNB1 promoter by chromatin immunoprecipitation assay (ChIP).
Introduction
Lamins (A, C, B1 and B2) are nuclear intermediate filament proteins with multifunctional characteristics 1 . They support the structural integrity of the nucleus, and play a key role in a wide range of nuclear functions, including transcription, DNA replication and repair, control of cell cycle and stem cell niche function, cell proliferation and differentiation of specific lineages during development and adult life 1, 2 . It has been demonstrated that tissue homeostasis can be disrupted by different mutations or abundance variation in lamins causing a variety of diseases, collectively termed laminopathies, including the premature aging syndrome HutchinsoneGilford progeria 3 . In recent years, the study on the lamins contributed to a better understanding of the phenomenon of cellular aging, tissue degeneration and pathogenesis of age-related diseases. Interestingly, changes of A:B lamin stoichiometry is correlated with stifness, and tissues such as cartilage and bone have a high A:B ratio 4 . Over-expression of lamin A or the presence of its mutant form progerin leads to defects in chondrogenic differentiation potential of mesenchymal stem cells (MSCs) 5 . High levels of lamin A were found in osteoarthritic chondrocytes 6 , whilst lamin B's contribution remains unexplored. Osteoarthritis (OA) is a common degenerative joint disease characterized by cellular senescence, loss of chondrocyte activity and degradation of articular cartilage 7 . Due to the complexity of these phenomena, there is a limited understanding in OA pathogenesis. The hypothesis to be explored is the possibility that chondrocyte response to various OA inducing conditions converges on de-differentiation and acquisition of stem cell-like properties. This might occur before reentry into the cell cycle or acquisition of the senescent phenotype. Clarifying this issue may be important to devise new approaches for OA prevention and treatment.
We recently found that Slug, an antichondrogenic transcription factor, is a marker of chondrocyte de-differentiation 8 . In order to find new Slug target molecules and to explore the partecipation of lamin B1 in the cartilage damage, we investigated their expression and molecular relationship in OA cartilage explants and in vitro dedifferentiated chondrocytes.
Material and methods

Cartilage explant analysis
Knee cartilage explants from normal subjects (at autopsy, n ¼ 3, age ¼ 55 ± 3 years, sex ¼ male, Mankin score ¼ 0e3) and OA patients (from joint replacement, n ¼ 6, age ¼ 58 ± 7 years, sex ¼ male, Mankin score ¼ 8e10) were fixed in a freshly prepared 9:1 mixture of B5 solution (mercuric-chloride containing fixative)/ 40% formaldehyde at room temperature for 2 h, dehydrated and embedded in paraffin as previously described 9 . The slides were then incubated using the following antibodies: b-galactosidase overnight at 4 C, washed and incubated with anti-goat-or goatanti-mouse/rabbit-biotinilated and alkaline phosphataseconjugated streptavidin (Kit BioGenex, San Ramon, CA, USA) at room temperature for 30 min. Slides were developed using new fast red as substrate and evaluated using a brightfield microscope. Safranin O staining was also performed. The study was approved by local ethical committee at Istituto Ortopedico Rizzoli.
Cell culture, immunofluorescence and gene expression analysis
Normal (n ¼ 3) and osteoarthritic chondrocytes (n ¼ 6) were isolated from articular cartilage by sequential enzymatic digestion as previously described 10 . Cells from passage 0 (p0) to passage 2 (p2) were grown on glass coverslips were fixed in methanol at À20 C for 7 min, blocked in 4% BSA-PBS and incubated with rabbit anti-human-Slug (clone H140, 1:10, Santa Cruz Biotechnology) and mouse anti-human Lamin B1 (clone 8D1, 1:100, Santa Cruz Biotechnology) overnight at 4 C. Coverslips were next washed and incubated with fluorescence-labeled secondary antibodies (SigmaeAldrich Chemical Co., St. Louis, MO) for 1 h at room temperature. Nuclei were counterstained with DAPI (4,6-diamino-2-phenylindole). Slides were mounted with antifade reagent in glycerol and observed with a Nikon E600 epifluorescence microscope (100Â magnification, 1,3 NA e numerical aperture) equipped with a digital camera. Images were processed using Adobe Photoshop (Adobe Systems).
Total RNA was extracted from cells at p0 and p2, reverse transcribed and PCR performed for collagen type I, collagen type II and Sox9 as previously described 10 .
Western blotting 20 mg of whole cell lysates were resolved by SDS-PAGE, transferred to PVDF (Millipore, Billerica, MA, USA) and blocked with PBS-0.05% Tween 20/5% NFDM, then probed overnight (4 C) with the following antibodies: Slug (mouse anti-human, clone A-7, 1:1000), Actin (mouse anti-human, clone C-2, 1:5000) from Santa Cruz Biotechnology, and Lamin B1 (rabbit anti-human 1:1500) from Abcam. After washing, the membranes were incubated with antimouse or anti-rabbit HRP conjugated antibodies (DAKO, Glostrup, Denmark) 1:2000, and signals were detected by Supersignal West Femto Substrate (Pierce, Rockford, IL, USA). Actin was used to confirm equal protein loading.
Chromatin immunoprecipitation assay (ChIP)
ChIP was performed using a CHIP assay kit (Upstate Biotechnology, Waltham, MA, USA) according to the manufacturer's instructions as previously described 8 . Chromatin samples from normal or OA chondrocytes were immunoprecipitated with a specific primary Slug antibody. IgG antibody was used as a negative control (all antibodies were purchased from Santa Cruz Biotechnology). 
Results
Loss of chondrocyte-specific properties was detected in degenerated cartilage tissue from OA patients. As shown in Fig. 1(A) , OA cartilage showed a low level of Safranin O staining for sulfated glicosaminoglycans, and increased senescenceassociated b-galactosidase and Lamin A immunostaining. This confirmed that a combination of phenomena including deterioration of tissue function and senescence occurs in OA cartilage. In search for new mediators of cartilage damage, we next analyzed tissue sections for the presence of another key player in cellular senescence, Lamin B1, and an anti-chondrogenic molecule, Slug transcription factor. Interestingly, the expression of Lamin B1 was increased in OA cartilage compared to normal samples and Slug colocalized with Lamin B1 [ Fig. 1(B) ]. Noteworthy, in normal cartilage few Slug-positive cells were present, both in the superficial/intermediate and deep area of the tissue. Conversely, a higher number of Slug-positive cells, located in all cartilage layers, were detected in OA cartilage. As senescence of chondrocytes is inherent to the OA process 7 , we state that Slug, in addition to being a marker of cell de-differentiation 8 , can also be associated to senescence. We confirmed this hypothesis in isolated normal and OA chondrocytes that were de-differentiated through prolonged passages in monolayer culture. In accordance with literature data 10, 11 , we confirmed the loss of the cartilagineous phenotype associated with de-differentiation process by demonstrating a decrease in the expression of typical chondrogenic markers, including collagen type II and Sox9, and an increase of collagen type I [ Fig. 2(A) ]. As previously demonstrated 8 , Slug protein gradually increased to very high levels during de-differentiation process of normal chondrocytes. This phenomenon was observed here, for the first time, also in OA chondrocytes, as shown by the immunoblot analysis reported in Fig. 2(A) . The same analysis revealed the presence of Lamin B1 in p0 chondrocytes and dedifferentiated p2 chondrocytes from healthy subjects and OA patients. Higher Slug levels were determined in OA samples compared with controls. This was confirmed by immunofluorescence analysis showing that Lamin B1 localized at the nuclear periphery, while Slug was mostly recruited in the nuclear interior [ Fig. 2(B) ].
These findings prompted us to establish the functional link between Slug and Lamin B1, investigating a possible role of Slug as regulator of Lamin B1 expression during chondrocyte dedifferentiation process. The possibility that Lamin B1 is a direct transcriptional target of Slug was examined by ChIP assay. By using the Transcription Element Search Software (TESS) for transcription factor search and MatInspector 7.4, we identified seven potential Slug binding sites (E-boxes, 5 0 -CANNTG/CANNTG-3 0 ) in the LMNB1 gene 5 0 regulatory region, six upstream and one downstream of the transcription start site. We focused on three chromatin subregions of LMNB1 promoter for "in vivo" E-box occupancy analysis. We observed Slug binding to Regions 1 and 3 in p2 OA chondrocytes, whereas Slug was mostly recruited at Region 1 and 2 in p0 normal chondrocytes [ Fig. 2(C) ]. Concomitant binding of acetylated histone H3 (Ac-H3) confirmed the active transcription of the locus (data not shown).
Discussion
An effective strategy to prevent cartilage loss or treat cartilage diseases is still lacking. Therefore, the search for potential molecular targets that are involved in the mechanisms of pathogenesis represents an important challenge. In this study, we described, for the first time, the upregulation of Slug and lamin B1 both in OA cartilage explants and in vitro de-differentiated chondrocytes, suggesting the implications of these molecules in two critical phenomena involved in onset of OA, the loss of cell differentiation and cellular senescence. We previously demonstrated that the inhibition of Slug, a transcriptional repressor of cartilage formation 12 , is effective in inducing chondrogenesis of mesenchymal stem cells 8 .
Our data evidence that Slug is involved in chondrocyte senescence, possibly due to its in vivo recruitment on the promoter of LMNB1 gene. However, further studies will be needed to dissect the way Slug can accomplish its task. Our results suggest that Slug might drive the loss of chondrocytic phenotype through regulation of Lamin B1 expression and lead us to speculate that Slug inhibition in culture-expanded chondrocytes could prevent the dedifferentiation process. Contrasting roles of Lamin B1 in cellular senescence have been described 13 . Reduced levels of Lamin B1 have been observed in HGPS patient-derived fibroblasts and senescent normal fibroblasts in vitro 13 . In one report, Lamin B1 silencing led to apoptosis in HeLa cells 14 , whereas recent work suggested that inhibition of Lamin B1 causes senescence in WI-38 cells 15 . Conversely, Lamin B1 overexpression appeared to enhance proliferation and delay the onset of senescence, whereas a second study showed that elevated levels of Lamin B1 triggered senescence 13 . Our data demonstrate a marked increase of Lamin B1 in OA chondrocytes, in favor of the hypothesis of its association with tissue degeneration and senescence.
Tissue degeneration and senescence involve a plethora of mediators so it is difficult to establish a hierarchy of events. Therefore, the key question is whether Slug and Lamin B1 are upstream or downstream the OA pathogenetic process. However, the proof of the in vivo molecular relationship between these two proteins could help to identify potential mechanisms by which catabolic changes in the articular cartilage lead to the onset of OA and to devise new approaches for the prevention and treatment of OA. Moreover, the evidences here described may help to improve cellbased therapies that use chondrocytes, helping to solve the problems of cellular senescence and de-differentiation that occur during in vitro expansion that represent one of the major practical barriers to clinical application. 
